InvestorsHub Logo
Followers 16
Posts 5825
Boards Moderated 0
Alias Born 07/16/2018

Re: None

Thursday, 04/02/2020 4:01:20 PM

Thursday, April 02, 2020 4:01:20 PM

Post# of 470043
FACTS ABOUT A2-73 RETT TRIALS:


https://clinicaltrials.gov/ct2/show/NCT03758924?term=Anavex&draw=2&rank=6

Study of ANAVEX2-73 in Patients With Rett Syndrome

21 participants: 6 PK open-label followed by 15 double-blind, randomized, placebo-controlled


Ages Eligible for Study:18 Years to 45 Years (Adult)





https://clinicaltrials.gov/ct2/show/NCT03941444?term=Anavex&draw=2&rank=5

ANAVEX2-73 Study in Patients With Rett Syndrome (AVATAR)


Ages Eligible for Study:18 Years to 45 Years(Adult)




https://clinicaltrials.gov/ct2/show/NCT04304482?term=Anavex&draw=2&rank=3

ANAVEX2-73 Study in Pediatric Patients With Rett Syndrome (EXCELLENCE)

Ages Eligible for Study: 5 Years to 18 Years(Child, Adult)





AVXL HAS RELEASED RETT TRIAL RESULTS FOR 6 ADULTS IN THE US ONLY!!!!!!!!!!!!


AVXL HAS RELEASED ZERO RETT RESULTS FOR GIRLS AND ZERO RETT RESULTS IN AUSTRALIA!!!!!!!!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News